Volume 16, issue 4, October 2010

For success in biotechnology, look beyond biotechnology

Authors

• Content type: Editorial
• Published: 25 October 2010
• Pages: 279 - 280

Federal bureaucrats slip on oil spill

Authors

• Content type: Commentary
• Published: 17 August 2010
• Pages: 281 - 283

R&D spending and sources of funding of private US biopharmaceutical firms seeking to go public

Authors

• Content type: Original Article
• Published: 17 August 2010
• Pages: 284 - 292

Algae and Biodiesel: Patenting energized as green goes commercial

Authors

• Content type: Original Article
• Published: 14 September 2010
• Pages: 293 - 312

Biotechnology industry-physician interaction and OIG guidelines: Evidence from the stock market

Authors

• Content type: Original Article
• Published: 25 October 2010
• Pages: 313 - 330

Exploratory assessment of the current EU regulatory framework for development of advanced therapies

Authors

• Content type: Original Article
• Published: 21 September 2010
• Pages: 331 - 336

Patenting of microorganisms: Systems and concerns

Authors

• Content type: Original Article
• Published: 21 September 2010
• Pages: 337 - 347

Legal and Regulatory Update

• Content type: Legal and Regulatory Update
• Published: 17 August 2010
• Pages: 348 - 357

The aftermath of Bilski

Authors

• Content type: Commentary
• Published: 25 October 2010
• Pages: 358 - 359

Commentary regarding decision in Bilski from a biotech perspective

Authors (first, second and last of 5)

• Content type: Commentary
• Published: 07 September 2010
• Pages: 360 - 361

Biodesign: The process of innovating medical technologies

Authors

• Content type: Book Review
• Published: 25 October 2010
• Pages: 362 - 364